cladribine has been researched along with Nevoxanthoendothelioma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Matsukawa, Y; Sakamoto, K; Shioda, Y | 1 |
| Bieber, T; Irnich, M; Maintz, L; Reinhard, H; Wenzel, J | 1 |
| Duncan, A; Parslew, R; Pizer, BL; Rajendra, B | 1 |
| Alla, CA; Arbion, F; Blouin, P; Colombat, P; Donadieu, J; Eitenschenck, L; Emile, JF; Machet, MC; Pagnier, A; Plantaz, D; Yvert, M | 1 |
| Inoue, M; Kawa, K; Nakayama, M; Sawada, A; Yamada, K; Yasui, M | 1 |
| Adam, Z; Koukalová, R; Král, Z; Krejčí, M; Mayer, J; Pour, L; Rehák, Z; Szturz, P; Tomíška, M; Zahradová, L | 1 |
| Lange, BJ; Nichols, KE; Orsey, A; Paessler, M | 1 |
3 review(s) available for cladribine and Nevoxanthoendothelioma
| Article | Year |
|---|---|
Successful treatment of systemic juvenile xanthogranulomatosis with cytarabine and 2-chlorodeoxyadenosine: case report and review of the literature.
Topics: Cladribine; Cytarabine; Dermatologic Agents; Drug Therapy, Combination; Humans; Infant; Male; Treatment Outcome; Xanthogranuloma, Juvenile | 2017 |
Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA-AraC.
Topics: Cladribine; Cytarabine; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Infant; Male; Xanthogranuloma, Juvenile | 2010 |
[Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
Topics: Adult; Antineoplastic Agents; Child; Cladribine; Histiocytosis, Langerhans-Cell; Histiocytosis, Non-Langerhans-Cell; Humans; Xanthogranuloma, Juvenile | 2012 |
4 other study(ies) available for cladribine and Nevoxanthoendothelioma
| Article | Year |
|---|---|
Refractory Extracutaneous Juvenile Xanthogranuloma With Multiple Intracranial Nodular Lesions Successfully Treated With 2-Chlorodeoxyadenosine.
Topics: Central Nervous System; Child; Cladribine; Humans; Skin; Treatment Outcome; Xanthogranuloma, Juvenile | 2022 |
Successful treatment of central nervous system juvenile xanthogranulomatosis with cladribine.
Topics: Central Nervous System Diseases; Cladribine; Follow-Up Studies; Humans; Infant; Male; Tomography, X-Ray Computed; Xanthogranuloma, Juvenile | 2009 |
Severe persistent bone marrow failure following therapy with 2-chlorodeoxyadenosine for relapsing juvenile xanthogranuloma of the brain.
Topics: Anemia, Aplastic; Bone Marrow Diseases; Bone Marrow Failure Disorders; Bone Marrow Transplantation; Brain Diseases; Child; Cladribine; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Prognosis; Recurrence; Transfusion Reaction; Xanthogranuloma, Juvenile | 2012 |
Central nervous system juvenile xanthogranuloma with malignant transformation.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Brain Neoplasms; Child; Cladribine; Dexamethasone; Diagnosis, Differential; Disease Progression; Fatal Outcome; Histiocytic Sarcoma; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Magnetic Resonance Imaging; Male; Pseudotumor Cerebri; Radiotherapy; Xanthogranuloma, Juvenile | 2008 |